SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

08 Nov 2023 Evaluate
The sales is pegged at Rs. 597.20 millions for the September 2023 quarter. The mentioned figure indicates a decline of about -43.95% as against Rs. 1065.40 millions during the year-ago period.The Net Loss for the quarter ended September 2023 is Rs. -57.80 millions as compared to Net Loss of Rs. -172.80 millions of corresponding quarter ended September 2022The company reported a good operating profit of 357.90 millions compared to 220.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 597.20 1065.40 -43.95 1292.70 2110.20 -38.74 4025.50 3066.10 31.29
Other Income 387.10 208.80 85.39 531.50 250.10 112.51 521.60 603.90 -13.63
PBIDT 357.90 220.30 62.46 452.10 295.90 52.79 599.20 999.00 -40.02
Interest 174.20 136.20 27.90 351.80 262.20 34.17 579.20 372.30 55.57
PBDT 153.20 84.10 82.16 69.80 33.70 107.12 0.00 567.60 -100.00
Depreciation 245.80 352.00 -30.17 492.70 698.50 -29.46 962.00 1400.70 -31.32
PBT -92.60 -267.90 -65.43 -422.90 -664.80 -36.39 -962.00 -833.10 15.47
TAX -34.80 -95.10 -63.41 -151.80 -243.70 -37.71 -373.30 -528.40 -29.35
Deferred Tax -34.80 -95.10 -63.41 -151.80 -243.70 -37.71 -373.30 -221.60 68.46
PAT -57.80 -172.80 -66.55 -271.10 -421.10 -35.62 -588.70 -304.70 93.21
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 59.93 20.68 189.83 34.97 14.02 149.41 14.89 32.58 -54.32

Dishman Carbogen Amc Share Price

168.60 -2.00 (-1.17%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×